1. Home
  2. OPTT vs DRMA Comparison

OPTT vs DRMA Comparison

Compare OPTT & DRMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ocean Power Technologies Inc.

OPTT

Ocean Power Technologies Inc.

HOLD

Current Price

$0.69

Market Cap

5.9M

Sector

Utilities

ML Signal

HOLD

Logo Dermata Therapeutics Inc.

DRMA

Dermata Therapeutics Inc.

HOLD

Current Price

$0.89

Market Cap

5.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPTT
DRMA
Founded
1984
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9M
5.6M
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
OPTT
DRMA
Price
$0.69
$0.89
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $45.00
N/A
AVG Volume (30 Days)
★ 679.5K
33.5K
Earning Date
09-14-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $3,737,000.00
N/A
Revenue This Year
$286.98
N/A
Revenue Next Year
$131.02
$650.00
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.10
$0.60
52 Week High
$3.23
$4.66

Technical Indicators

Market Signals
Indicator
OPTT
DRMA
Relative Strength Index (RSI) 39.57 36.63
Support Level $0.29 N/A
Resistance Level $3.23 $1.40
Average True Range (ATR) 0.19 0.10
MACD -0.12 -0.03
Stochastic Oscillator 3.19 45.60

Price Performance

Historical Comparison
OPTT
DRMA

About OPTT Ocean Power Technologies Inc.

Ocean Power Technologies Inc is specializing in intelligent maritime solutions. These solutions include a variety of as a service systems, including Data as a Service (DaaS), Robotics as a Service (RaaS), and Power as a Service (PaaS). It design, manufacture, deploy, and operate these systems for defense, security, subsea infrastructure, offshore oil and gas, offshore energy, marine research, and communication markets. The company operates as one operating segment. Majority of revenue comes from Europe followed by North & South America; and followed by Asia and Australia.

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis, rosacea, and seborrheic dermatitis. The company is currently developing a once-weekly acne treatment system that utilizes an active ingredient from the OTC monograph in combination with the company's Spongilla technology. It intends to apply its Spongilla technology platform across a range of dermatologic and aesthetic skin applications, including intradermal delivery of botulinum toxin. The company's operates in one segment, which is the business of developing, branding, marketing, and commercializing direct to consumer skincare products.

Share on Social Networks: